Department of Urology,
Veterans Affairs Medical Center,
San Francisco,
Department of Urology, Veterans Affairs Medical Center, San Francisco
Rajvir Dahiya has not added Biography.
If you are Rajvir Dahiya and would like to personalize this page please email our Author Liaison for assistance.
DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.
The Journal of urology Jan, 2002 | Pubmed ID: 11743352
DNA methyltransferase and demethylase in human prostate cancer.
Molecular carcinogenesis Mar, 2002 | Pubmed ID: 11870882
Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
Journal of the National Cancer Institute Mar, 2002 | Pubmed ID: 11880477
Effects of aging on growth factors gene and protein expression in the dorsal and ventral lobes of rat prostate.
Biochemical and biophysical research communications Mar, 2002 | Pubmed ID: 11906188
Transforming growth factor-beta(s) and their receptors in aging rat prostate.
Biochemical and biophysical research communications Jun, 2002 | Pubmed ID: 12051734
The bladder acellular matrix graft in a rat chemical cystitis model: functional and histologic evaluation.
The Journal of urology Aug, 2002 | Pubmed ID: 12131370
Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer.
Biochemical and biophysical research communications Aug, 2002 | Pubmed ID: 12200121
CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Molecular carcinogenesis Aug, 2002 | Pubmed ID: 12203370
Single nucleotide polymorphisms of estrogen receptor alpha in human renal cell carcinoma.
Biochemical and biophysical research communications Sep, 2002 | Pubmed ID: 12207901
Homologous acellular matrix graft for vaginal repair in rats: a pilot study for a new reconstructive approach.
World journal of urology Sep, 2002 | Pubmed ID: 12215858
Polymorphisms of estrogen receptor alpha gene in endometrial cancer.
Biochemical and biophysical research communications Sep, 2002 | Pubmed ID: 12270131
Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 Genes in bladder cancer.
The Journal of urology Nov, 2002 | Pubmed ID: 12394763
Loss of anti-apoptotic genes in aging rat crura.
The Journal of urology Nov, 2002 | Pubmed ID: 12394778
MethPrimer: designing primers for methylation PCRs.
Bioinformatics (Oxford, England) Nov, 2002 | Pubmed ID: 12424112
Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1.
International journal of oncology Jan, 2003 | Pubmed ID: 12469199
PGDB: a curated and integrated database of genes related to the prostate.
Nucleic acids research Jan, 2003 | Pubmed ID: 12520005
Hormonal, cellular, and molecular control of prostatic development.
Developmental biology Jan, 2003 | Pubmed ID: 12645922
Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
Biochemical and biophysical research communications Mar, 2003 | Pubmed ID: 12646234
Spontaneous mutation in mice provides new insight into the genetic mechanisms that pattern the seminal vesicles and prostate gland.
Developmental dynamics : an official publication of the American Association of Anatomists Apr, 2003 | Pubmed ID: 12666202
The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients.
Biochemical and biophysical research communications Jun, 2003 | Pubmed ID: 12767946
Estrogen receptor alpha polymorphisms and renal cell carcinoma--a possible risk.
Molecular and cellular endocrinology Apr, 2003 | Pubmed ID: 12770739
CYP1B1 gene in endometrial cancer.
Molecular and cellular endocrinology Apr, 2003 | Pubmed ID: 12770747
Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers.
Molecular and cellular endocrinology Apr, 2003 | Pubmed ID: 12770752
DNA mismatch repair genes in renal cell carcinoma.
The Journal of urology Jun, 2003 | Pubmed ID: 12771799
The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2003 | Pubmed ID: 12796377
Diabetes induced erectile dysfunction and apoptosis in penile crura are recovered by insulin treatment in rats.
The Journal of urology Jul, 2003 | Pubmed ID: 12796708
Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Cancer research Jun, 2003 | Pubmed ID: 12810635
CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions.
Cancer research Jul, 2003 | Pubmed ID: 12873984
Polymorphisms of estrogen receptor alpha in prostate cancer.
Molecular carcinogenesis Aug, 2003 | Pubmed ID: 12891629
Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations.
European journal of clinical pharmacology Sep, 2003 | Pubmed ID: 12923601
Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation.
Biochemical and biophysical research communications Sep, 2003 | Pubmed ID: 12951050
Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF.
International journal of oncology Oct, 2003 | Pubmed ID: 12964000
Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
Cancer research Nov, 2003 | Pubmed ID: 14633696
The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations.
Biochemical and biophysical research communications Dec, 2003 | Pubmed ID: 14652007
Alleles of polymorphic sites that correspond to hyperactive variants of CYP1B1 protein are significantly less frequent in Japanese as compared to American and German populations.
Human mutation Jun, 2003 | Pubmed ID: 14961553
Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Mar, 2004 | Pubmed ID: 15041720
Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
Biochemical and biophysical research communications Apr, 2004 | Pubmed ID: 15044106
Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Biochemical and biophysical research communications Jul, 2004 | Pubmed ID: 15240098
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Cancer research Sep, 2004 | Pubmed ID: 15342374
Age-dependent methylation of ESR1 gene in prostate cancer.
Biochemical and biophysical research communications Aug, 2004 | Pubmed ID: 15358197
Distribution of a single nucleotide polymorphism on codon 211 of the androgen receptor gene and its correlation with human renal cell cancer in Japanese patients.
Biochemical and biophysical research communications Aug, 2004 | Pubmed ID: 15358199
DNA methylation in prostate cancer.
Biochimica et biophysica acta Sep, 2004 | Pubmed ID: 15363862
Human papilloma virus type 16 infection and the early onset of cervical cancer.
Biochemical and biophysical research communications Oct, 2004 | Pubmed ID: 15369795
Kidney gene database: a curated and integrated database of genes involved in kidney disease.
The Journal of urology Dec, 2004 | Pubmed ID: 15538263
Inactivation of the hMSH3 mismatch repair gene in bladder cancer.
Biochemical and biophysical research communications Dec, 2004 | Pubmed ID: 15541380
Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura.
The Journal of urology Jan, 2005 | Pubmed ID: 15592104
Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment.
Urology Dec, 2004 | Pubmed ID: 15596216
Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Journal of the National Cancer Institute Jan, 2005 | Pubmed ID: 15657340
Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2005 | Pubmed ID: 15701841
Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2005 | Pubmed ID: 15709168
GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients.
Biochemical and biophysical research communications Apr, 2005 | Pubmed ID: 15721279
Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
Cancer research Mar, 2005 | Pubmed ID: 15781623
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
International journal of cancer. Journal international du cancer Aug, 2005 | Pubmed ID: 15800905
CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
Cancer Jul, 2005 | Pubmed ID: 15895377
Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: histologic and functional evaluation.
Urology Jul, 2005 | Pubmed ID: 15992890
Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.
Oncogene Oct, 2005 | Pubmed ID: 16007175
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2005 | Pubmed ID: 16115918
WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma.
Cancer Nov, 2005 | Pubmed ID: 16134181
Multigene methylation analysis for detection and staging of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2005 | Pubmed ID: 16166436
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.
Cancer Jan, 2006 | Pubmed ID: 16323173
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2006 | Pubmed ID: 16428476
Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat.
Biochemical and biophysical research communications Mar, 2006 | Pubmed ID: 16455052
Collagen I:III ratio in canine heterologous bladder acellular matrix grafts.
World journal of urology Feb, 2006 | Pubmed ID: 16474953
Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Feb, 2006 | Pubmed ID: 16492910
Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
Biochemical and biophysical research communications Apr, 2006 | Pubmed ID: 16510122
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2006 | Pubmed ID: 16609023
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.
The Journal of urology Aug, 2006 | Pubmed ID: 16813949
Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer.
Cancer research Aug, 2006 | Pubmed ID: 16885337
Small dsRNAs induce transcriptional activation in human cells.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2006 | Pubmed ID: 17085592
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2006 | Pubmed ID: 17145819
Polymorphisms of DNA repair genes are risk factors for prostate cancer.
European journal of cancer (Oxford, England : 1990) Jan, 2007 | Pubmed ID: 17196815
Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Jan, 2007 | Pubmed ID: 17220335
Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the rat.
World journal of urology Apr, 2007 | Pubmed ID: 17221271
A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins.
Biochemical and biophysical research communications Mar, 2007 | Pubmed ID: 17266926
Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer.
Molecular carcinogenesis Oct, 2007 | Pubmed ID: 17415778
Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2007 | Pubmed ID: 17473182
MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2007 | Pubmed ID: 17634539
CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2007 | Pubmed ID: 17785557
A dioxin-responsive enhancer 3' of the human CYP1A2 gene.
Molecular pharmacology Dec, 2007 | Pubmed ID: 17785579
MicroRNA-373 induces expression of genes with complementary promoter sequences.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2008 | Pubmed ID: 18227514
CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Cancer May, 2008 | Pubmed ID: 18318428
COMT polymorphisms affecting protein expression are risk factors for endometrial cancer.
Molecular carcinogenesis Oct, 2008 | Pubmed ID: 18324659
Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells.
Molecular cancer therapeutics Mar, 2008 | Pubmed ID: 18347154
Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer.
The Journal of urology May, 2008 | Pubmed ID: 18355840
DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
International journal of cancer. Journal international du cancer Aug, 2008 | Pubmed ID: 18404682
Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification.
Cancer research Apr, 2008 | Pubmed ID: 18413741
Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.
International journal of cancer. Journal international du cancer Aug, 2008 | Pubmed ID: 18431742
Frizzled-7 as a potential therapeutic target in colorectal cancer.
Neoplasia (New York, N.Y.) Jul, 2008 | Pubmed ID: 18592008
Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function.
Molecular cancer therapeutics Oct, 2008 | Pubmed ID: 18852123
Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder.
BJU international May, 2009 | Pubmed ID: 18990142
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
Carcinogenesis Apr, 2009 | Pubmed ID: 19221000
Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention.
Cancer prevention research (Philadelphia, Pa.) Mar, 2009 | Pubmed ID: 19223575
Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.
The Journal of urology Apr, 2009 | Pubmed ID: 19237173
Double stranded-RNA-mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma.
International journal of cancer. Journal international du cancer Jul, 2009 | Pubmed ID: 19384944
The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.
The Journal of urology Aug, 2009 | Pubmed ID: 19539330
Wnt antagonist gene polymorphisms and renal cancer.
Cancer Oct, 2009 | Pubmed ID: 19562778
Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis.
Cancer research Sep, 2009 | Pubmed ID: 19690133
Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Cancer research Sep, 2009 | Pubmed ID: 19723665
Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2009 | Pubmed ID: 19755393
Restoring erectile function by antioxidant therapy in diabetic rats.
The Journal of urology Nov, 2009 | Pubmed ID: 19765757
Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.
Cancer Jan, 2010 | Pubmed ID: 19885928
Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Cancer research Nov, 2009 | Pubmed ID: 19887605
Role of secreted frizzled-related protein 3 in human renal cell carcinoma.
Cancer research Mar, 2010 | Pubmed ID: 20160027
Diet, microRNAs and prostate cancer.
Pharmaceutical research Jun, 2010 | Pubmed ID: 20221895
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.
Cancer research Apr, 2010 | Pubmed ID: 20332239
Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.
International journal of cancer. Journal international du cancer Feb, 2011 | Pubmed ID: 20340127
Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer.
Molecular cancer therapeutics Jun, 2010 | Pubmed ID: 20501806
Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
International journal of cancer. Journal international du cancer Apr, 2011 | Pubmed ID: 20549706
Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer.
Carcinogenesis Sep, 2010 | Pubmed ID: 20554747
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer.
Cancer Dec, 2010 | Pubmed ID: 20737563
Cytochrome P450 17 (CYP17) is involved in endometrial cancinogenesis through apoptosis and invasion pathways.
Molecular carcinogenesis Jan, 2011 | Pubmed ID: 20886547
A heart with 67 stents.
Journal of the American College of Cardiology Nov, 2010 | Pubmed ID: 21029877
MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.
Cancer prevention research (Philadelphia, Pa.) Jan, 2011 | Pubmed ID: 21071579
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2011 | Pubmed ID: 21159887
IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.
International journal of cancer. Journal international du cancer Nov, 2011 | Pubmed ID: 21207373
Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Molecular carcinogenesis Jun, 2011 | Pubmed ID: 21268126
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.
Cancer research Apr, 2011 | Pubmed ID: 21330408
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.
Carcinogenesis May, 2011 | Pubmed ID: 21349819
DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma.
Cancer Apr, 2011 | Pubmed ID: 21472712
Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.
Cancer prevention research (Philadelphia, Pa.) Oct, 2011 | Pubmed ID: 21836020
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells.
Cancer research Oct, 2011 | Pubmed ID: 21852381
Graded activation of the MEK1/MT1-MMP axis determines renal epithelial cell tumor phenotype.
Carcinogenesis Dec, 2011 | Pubmed ID: 21965271
The complex roles of Wnt antagonists in RCC.
Nature reviews. Urology Dec, 2011 | Pubmed ID: 22025172
MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
Carcinogenesis Jan, 2012 | Pubmed ID: 22049531
Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.
Molecular cancer therapeutics Jan, 2012 | Pubmed ID: 22057916
MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
Carcinogenesis Feb, 2012 | Pubmed ID: 22159222
Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.
Carcinogenesis Feb, 2012 | Pubmed ID: 22159223
Possible involvement of Wnt11 in colorectal cancer progression.
Molecular carcinogenesis Mar, 2013 | Pubmed ID: 22161723
MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
Carcinogenesis Mar, 2012 | Pubmed ID: 22180573
MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
PloS one , 2012 | Pubmed ID: 22235332
Wnt signaling pathways in urological cancers: past decades and still growing.
Molecular cancer , 2012 | Pubmed ID: 22325146
Up-regulation of microRNA-21 correlates with lower kidney cancer survival.
PloS one , 2012 | Pubmed ID: 22347428
miRNA-708 control of CD44(+) prostate cancer-initiating cells.
Cancer research Jul, 2012 | Pubmed ID: 22552290
5-Aza-2'-deoxycytidine stress response and apoptosis in prostate cancer.
Clinical epigenetics Aug, 2011 | Pubmed ID: 22704346
Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.
International journal of cancer. Journal international du cancer Apr, 2013 | Pubmed ID: 22833265
Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.
PloS one , 2012 | Pubmed ID: 22928040
Simultaneous implantation of bilateral ureters into bladder acellular matrix graft after partial cystectomy in a porcine model.
BJU international Dec, 2012 | Pubmed ID: 23046198
MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer.
PloS one , 2012 | Pubmed ID: 23056431
miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
Cancer research Dec, 2012 | Pubmed ID: 23074286
miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2013 | Pubmed ID: 23147995
Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.
PloS one , 2012 | Pubmed ID: 23189187
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.
PloS one , 2012 | Pubmed ID: 23226455
MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.
PloS one , 2013 | Pubmed ID: 23383207
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
PloS one , 2013 | Pubmed ID: 23554959
Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells.
Molecular cancer therapeutics Jun, 2013 | Pubmed ID: 23580416
MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.
PloS one , 2013 | Pubmed ID: 23844063
Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.
PloS one , 2013 | Pubmed ID: 23936419
MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases.
PloS one , 2013 | Pubmed ID: 24223753
Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.
The Journal of biological chemistry May, 2014 | Pubmed ID: 24616104
Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.
Oncotarget Apr, 2014 | Pubmed ID: 24755523
Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.
Molecular cancer therapeutics Jul, 2014 | Pubmed ID: 24817628
Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Oct, 2014 | Pubmed ID: 25027399
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.
Oncotarget Nov, 2014 | Pubmed ID: 25526032
Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.
Cancer research Apr, 2015 | Pubmed ID: 25600645
Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
Oncotarget Apr, 2015 | Pubmed ID: 25797254
Versican is a potential therapeutic target in docetaxel-resistant prostate cancer.
Oncoscience , 2015 | Pubmed ID: 25859560
Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.
Oncotarget Apr, 2015 | Pubmed ID: 25860934
Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.
Oncotarget Jun, 2015 | Pubmed ID: 26036629
CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.
BMC cancer , 2015 | Pubmed ID: 26626260
Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.
Oncotarget May, 2016 | Pubmed ID: 27203547
MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma.
Molecular cancer therapeutics Dec, 2017 | Pubmed ID: 28802251
MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
Molecular cancer therapeutics 05, 2018 | Pubmed ID: 29440295
Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished Expression.
Molecular cancer research : MCR 11, 2018 | Pubmed ID: 30037856
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados